Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
49 hedge funds and large institutions have $389M invested in Omega Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
69% more capital invested
Capital invested by funds: $231M → $389M (+$158M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
11% more funds holding
Funds holding: 44 → 49 (+5)
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
8% less call options, than puts
Call options by funds: $314K | Put options by funds: $343K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$375K |
| 2 |
Citigroup
New York
|
+$168K |
| 3 |
6CM
683 Capital Management
New York
|
+$153K |
| 4 |
Millennium Management
New York
|
+$112K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$107K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$467K |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$266K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$132K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$87.2K |
| 5 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$63K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
LPL Financial
San Diego,
California
| – | -$56K | -10,392 | Closed |
|
OMGA Hedge Fund Activity: Q4 2022 in Review
49 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q4 2022, worth a combined $389M — up 69% from $231M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new OMGA positions and 2 closed out — a net gain of 5 holders — while 12 added to existing stakes and 13 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $375K. The largest seller was BlackRock, cutting an estimated $467K.
- 49 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q4 2022, up from 44 in Q3 2022.
- Funds reported $389M of Omega Therapeutics, Inc. Common Stock stock for Q4 2022, up 69% quarter-over-quarter.
- 7 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q4 2022 and 2 closed out, a net change of +5 holders.
- The largest Omega Therapeutics, Inc. Common Stock buyer in Q4 2022 was Susquehanna International Group, an estimated $375K added.
- The largest Omega Therapeutics, Inc. Common Stock seller in Q4 2022 was BlackRock, an estimated $467K sold.
Based on aggregated 13F filings for Q4 2022.